How much does a course of Necitumumab cost?

Necitumumab is used in combination with gemcitabine and cisplatin to treat squamous non-small cell lung cancer that has spread. Nexitolizumab interferes with the growth of cancer cells, which are eventually destroyed by the body. Because the growth of normal somatic cells may also be affected by nexituzumab, other adverse effects may occur. Some of these may be serious, such as a rash, which may not be serious but may be cause for concern. Some adverse reactions may appear months or years after taking the medication. This medicine should only be taken by a doctor or under his supervision.

The recommended dose of nexituzumab is 800 mg (fixed dose) as a 60-minute intravenous infusion on days 1 and 8 of each 3-week cycle. If a decrease in the infusion rate is shown, the duration of the infusion should not exceed 2 hours. Nexituzumab was given in addition to gemcitabine and cisplatin-based chemotherapy for up to 6 cycles and then as a single agent in patients whose disease had not progressed until disease progression or unacceptable toxicity. Nexituzumab injections may cause serious and life-threatening heart rhythm and breathing problems, and your doctor will order certain tests to check how your body is responding to Nexituzumab before your infusion, during your infusion, and for at least 8 weeks after your last dose.

The generic drug of Nexituzumab has not yet been approved for marketing in China, and therefore it has not been included in medical insurance. The German version of the generic version of Nexituzumab 800mg/50ml marketed overseas may cost more than RMB 10,000 per box (the price may fluctuate due to exchange rates), which is relatively expensive. There are currently no generic versions of Nexituzumab available on the market. For more drug information and specific prices, please consult Yaode Medical Consultant.